» Articles » PMID: 38190384

Supporting Self-management for Patients with Interstitial Lung Diseases: Utility and Acceptability of Digital Devices

Abstract

Introduction: Patients diagnosed with Interstitial Lung Diseases (ILD) use devices to self-monitor their health and well-being. Little is known about the range of devices, selection, frequency and terms of use and overall utility. We sought to quantify patients' usage and experiences with home digital devices, and further evaluate their perceived utility and barriers to adaptation.

Methods: A team of expert clinicians and patient partners interested in self-management approaches designed a 48-question cross-sectional electronic survey; specifically targeted at individuals diagnosed with ILD. The survey was critically appraised by the interdisciplinary self-management group at Royal Devon University Hospitals NHS Foundation Trust during a 6-month validation process. The survey was open for participation between September 2021 and December 2022, and responses were collected anonymously. Data were analysed descriptively for quantitative aspects and through thematic analysis for qualitative input.

Results: 104 patients accessed the survey and 89/104 (86%) reported a diagnosis of lung fibrosis, including 46/89 (52%) idiopathic pulmonary fibrosis (IPF) with 57/89 (64%) of participants diagnosed >3 years and 59/89 (66%) female. 52/65(80%) were in the UK; 33/65 (51%) reported severe breathlessness medical research council MRC grade 3-4 and 32/65 (49%) disclosed co-morbid arthritis or joint problems. Of these, 18/83 (22%) used a hand- held spirometer, with only 6/17 (35%) advised on how to interpret the readings. Pulse oximetry devices were the most frequently used device by 35/71 (49%) and 20/64 (31%) measured their saturations more than once daily. 29/63 (46%) of respondents reported home-monitoring brought reassurance; of these, for 25/63 (40%) a feeling of control. 10/57 (18%) felt it had a negative effect, citing fluctuating readings as causing stress and 'paranoia'. The most likely help-seeking triggers were worsening breathlessness 53/65 (82%) and low oxygen saturation 43/65 (66%). Nurse specialists were the most frequent source of help 24/63 (38%). Conclusion: Patients can learn appropriate technical skills, yet perceptions of home-monitoring are variable; targeted assessment and tailored support is likely to be beneficial.

Citing Articles

The role of digital health in respiratory diseases management: a narrative review of recent literature.

Althobiani M, Russell A, Jacob J, Ranjan Y, Ahmad R, Folarin A Front Med (Lausanne). 2025; 12:1361667.

PMID: 40078397 PMC: 11896871. DOI: 10.3389/fmed.2025.1361667.

References
1.
Marcoux V, Wang M, Burgoyne S, Fell C, Ryerson C, Sajobi T . Mobile Health Monitoring in Patients with Idiopathic Pulmonary Fibrosis. Ann Am Thorac Soc. 2019; 16(10):1327-1329. DOI: 10.1513/AnnalsATS.201904-335RL. View

2.
Maher T, Schiffman C, Kreuter M, Moor C, Nathan S, Axmann J . A review of the challenges, learnings and future directions of home handheld spirometry in interstitial lung disease. Respir Res. 2022; 23(1):307. PMC: 9651119. DOI: 10.1186/s12931-022-02221-4. View

3.
Velardo C, Shah S, Gibson O, Clifford G, Heneghan C, Rutter H . Digital health system for personalised COPD long-term management. BMC Med Inform Decis Mak. 2017; 17(1):19. PMC: 5319140. DOI: 10.1186/s12911-017-0414-8. View

4.
Kalluri M, Orenstein S, Archibald N, Pooler C . Advance Care Planning Needs in Idiopathic Pulmonary Fibrosis: A Qualitative Study. Am J Hosp Palliat Care. 2021; 39(6):641-651. PMC: 9082969. DOI: 10.1177/10499091211041724. View

5.
Moor C, Wapenaar M, Miedema J, Geelhoed J, Chandoesing P, Wijsenbeek M . A home monitoring program including real-time wireless home spirometry in idiopathic pulmonary fibrosis: a pilot study on experiences and barriers. Respir Res. 2018; 19(1):105. PMC: 5975585. DOI: 10.1186/s12931-018-0810-3. View